| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-13 11:53:29 UTC |
|---|
| Update Date | 2022-03-07 02:57:14 UTC |
|---|
| HMDB ID | HMDB0042020 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Talinolol |
|---|
| Description | Talinolol, also known as talinolol acetate or cordanum, belongs to the class of organic compounds known as n-phenylureas. N-phenylureas are compounds containing a N-phenylurea moiety, which is structurally characterized by a phenyl group linked to one nitrogen atom of a urea group. Based on a literature review very few articles have been published on Talinolol. |
|---|
| Structure | CC(C)(C)NCC(O)COC1=CC=C(NC(O)=NC2CCCCC2)C=C1 InChI=1S/C20H33N3O3/c1-20(2,3)21-13-17(24)14-26-18-11-9-16(10-12-18)23-19(25)22-15-7-5-4-6-8-15/h9-12,15,17,21,24H,4-8,13-14H2,1-3H3,(H2,22,23,25) |
|---|
| Synonyms | | Value | Source |
|---|
| Talinolol monohydrochloride | HMDB | | Talinolol oxalate (2:1) | HMDB | | Talinolol, (+-)-isomer | HMDB | | Talinolol acetate | HMDB | | Talinolol nitrate | HMDB | | Cordanum | HMDB | | Talinolol mononitrate | HMDB | | Talinolol oxalate | HMDB | | Talinolol sulfate (2:1) | HMDB | | Talinolol tartrate (2:1), L-(+)-isomer | HMDB | | Talinolol tartrate, L-(+)-isomer | HMDB | | 1-(4-Cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane | HMDB | | Talinolol benzoate | HMDB | | Talinolol hydrochloride | HMDB | | Talinolol monoacetate | HMDB | | Talinolol monosalicylate | HMDB | | Talinolol salicylate | HMDB | | Talinolol sulfate | HMDB |
|
|---|
| Chemical Formula | C20H33N3O3 |
|---|
| Average Molecular Weight | 363.4943 |
|---|
| Monoisotopic Molecular Weight | 363.252191937 |
|---|
| IUPAC Name | N-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N'-cyclohexylcarbamimidic acid |
|---|
| Traditional Name | (+-)-talinolol |
|---|
| CAS Registry Number | 57460-41-0 |
|---|
| SMILES | CC(C)(C)NCC(O)COC1=CC=C(NC(O)=NC2CCCCC2)C=C1 |
|---|
| InChI Identifier | InChI=1S/C20H33N3O3/c1-20(2,3)21-13-17(24)14-26-18-11-9-16(10-12-18)23-19(25)22-15-7-5-4-6-8-15/h9-12,15,17,21,24H,4-8,13-14H2,1-3H3,(H2,22,23,25) |
|---|
| InChI Key | MXFWWQICDIZSOA-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as n-phenylureas. N-phenylureas are compounds containing a N-phenylurea moiety, which is structurally characterized by a phenyl group linked to one nitrogen atom of a urea group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | N-phenylureas |
|---|
| Direct Parent | N-phenylureas |
|---|
| Alternative Parents | |
|---|
| Substituents | - N-phenylurea
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- 1,2-aminoalcohol
- Urea
- Secondary alcohol
- Carbonic acid derivative
- Secondary aliphatic amine
- Ether
- Secondary amine
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Amine
- Organic oxygen compound
- Alcohol
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.11 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.2789 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.94 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 82.1 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1908.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 176.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 162.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 161.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 103.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 359.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 425.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 180.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 842.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 402.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1151.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 257.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 290.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 297.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 295.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 18.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Talinolol,1TMS,isomer #1 | CC(C)(C)NCC(COC1=CC=C(NC(O)=NC2CCCCC2)C=C1)O[Si](C)(C)C | 3129.0 | Semi standard non polar | 33892256 | | Talinolol,1TMS,isomer #2 | CC(C)(C)NCC(O)COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C)C=C1 | 3091.0 | Semi standard non polar | 33892256 | | Talinolol,1TMS,isomer #3 | CC(C)(C)N(CC(O)COC1=CC=C(NC(O)=NC2CCCCC2)C=C1)[Si](C)(C)C | 3264.6 | Semi standard non polar | 33892256 | | Talinolol,1TMS,isomer #4 | CC(C)(C)NCC(O)COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C)C=C1 | 3080.5 | Semi standard non polar | 33892256 | | Talinolol,2TMS,isomer #1 | CC(C)(C)NCC(COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C)C=C1)O[Si](C)(C)C | 3003.2 | Semi standard non polar | 33892256 | | Talinolol,2TMS,isomer #2 | CC(C)(C)N(CC(COC1=CC=C(NC(O)=NC2CCCCC2)C=C1)O[Si](C)(C)C)[Si](C)(C)C | 3277.3 | Semi standard non polar | 33892256 | | Talinolol,2TMS,isomer #3 | CC(C)(C)NCC(COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C)C=C1)O[Si](C)(C)C | 2987.3 | Semi standard non polar | 33892256 | | Talinolol,2TMS,isomer #4 | CC(C)(C)N(CC(O)COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C)C=C1)[Si](C)(C)C | 3187.0 | Semi standard non polar | 33892256 | | Talinolol,2TMS,isomer #5 | CC(C)(C)NCC(O)COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C)[Si](C)(C)C)C=C1 | 2954.3 | Semi standard non polar | 33892256 | | Talinolol,2TMS,isomer #6 | CC(C)(C)N(CC(O)COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C)C=C1)[Si](C)(C)C | 3173.9 | Semi standard non polar | 33892256 | | Talinolol,3TMS,isomer #1 | CC(C)(C)N(CC(COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C)C=C1)O[Si](C)(C)C)[Si](C)(C)C | 3188.6 | Semi standard non polar | 33892256 | | Talinolol,3TMS,isomer #1 | CC(C)(C)N(CC(COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C)C=C1)O[Si](C)(C)C)[Si](C)(C)C | 2783.1 | Standard non polar | 33892256 | | Talinolol,3TMS,isomer #2 | CC(C)(C)NCC(COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C)[Si](C)(C)C)C=C1)O[Si](C)(C)C | 2872.8 | Semi standard non polar | 33892256 | | Talinolol,3TMS,isomer #2 | CC(C)(C)NCC(COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C)[Si](C)(C)C)C=C1)O[Si](C)(C)C | 2736.5 | Standard non polar | 33892256 | | Talinolol,3TMS,isomer #3 | CC(C)(C)N(CC(COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C)C=C1)O[Si](C)(C)C)[Si](C)(C)C | 3181.7 | Semi standard non polar | 33892256 | | Talinolol,3TMS,isomer #3 | CC(C)(C)N(CC(COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C)C=C1)O[Si](C)(C)C)[Si](C)(C)C | 2927.3 | Standard non polar | 33892256 | | Talinolol,3TMS,isomer #4 | CC(C)(C)N(CC(O)COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C)[Si](C)(C)C)C=C1)[Si](C)(C)C | 3080.2 | Semi standard non polar | 33892256 | | Talinolol,3TMS,isomer #4 | CC(C)(C)N(CC(O)COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C)[Si](C)(C)C)C=C1)[Si](C)(C)C | 2888.5 | Standard non polar | 33892256 | | Talinolol,4TMS,isomer #1 | CC(C)(C)N(CC(COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C)[Si](C)(C)C)C=C1)O[Si](C)(C)C)[Si](C)(C)C | 3129.8 | Semi standard non polar | 33892256 | | Talinolol,4TMS,isomer #1 | CC(C)(C)N(CC(COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C)[Si](C)(C)C)C=C1)O[Si](C)(C)C)[Si](C)(C)C | 2866.4 | Standard non polar | 33892256 | | Talinolol,1TBDMS,isomer #1 | CC(C)(C)NCC(COC1=CC=C(NC(O)=NC2CCCCC2)C=C1)O[Si](C)(C)C(C)(C)C | 3344.4 | Semi standard non polar | 33892256 | | Talinolol,1TBDMS,isomer #2 | CC(C)(C)NCC(O)COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)C=C1 | 3317.4 | Semi standard non polar | 33892256 | | Talinolol,1TBDMS,isomer #3 | CC(C)(C)N(CC(O)COC1=CC=C(NC(O)=NC2CCCCC2)C=C1)[Si](C)(C)C(C)(C)C | 3498.7 | Semi standard non polar | 33892256 | | Talinolol,1TBDMS,isomer #4 | CC(C)(C)NCC(O)COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C(C)(C)C)C=C1 | 3304.4 | Semi standard non polar | 33892256 | | Talinolol,2TBDMS,isomer #1 | CC(C)(C)NCC(COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C | 3410.7 | Semi standard non polar | 33892256 | | Talinolol,2TBDMS,isomer #2 | CC(C)(C)N(CC(COC1=CC=C(NC(O)=NC2CCCCC2)C=C1)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3727.5 | Semi standard non polar | 33892256 | | Talinolol,2TBDMS,isomer #3 | CC(C)(C)NCC(COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C | 3424.3 | Semi standard non polar | 33892256 | | Talinolol,2TBDMS,isomer #4 | CC(C)(C)N(CC(O)COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C | 3646.9 | Semi standard non polar | 33892256 | | Talinolol,2TBDMS,isomer #5 | CC(C)(C)NCC(O)COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1 | 3370.9 | Semi standard non polar | 33892256 | | Talinolol,2TBDMS,isomer #6 | CC(C)(C)N(CC(O)COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C | 3652.0 | Semi standard non polar | 33892256 | | Talinolol,3TBDMS,isomer #1 | CC(C)(C)N(CC(COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3844.3 | Semi standard non polar | 33892256 | | Talinolol,3TBDMS,isomer #1 | CC(C)(C)N(CC(COC1=CC=C(NC(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3272.4 | Standard non polar | 33892256 | | Talinolol,3TBDMS,isomer #2 | CC(C)(C)NCC(COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C | 3441.0 | Semi standard non polar | 33892256 | | Talinolol,3TBDMS,isomer #2 | CC(C)(C)NCC(COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C | 3204.8 | Standard non polar | 33892256 | | Talinolol,3TBDMS,isomer #3 | CC(C)(C)N(CC(COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3844.1 | Semi standard non polar | 33892256 | | Talinolol,3TBDMS,isomer #3 | CC(C)(C)N(CC(COC1=CC=C(N(C(O)=NC2CCCCC2)[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3421.1 | Standard non polar | 33892256 | | Talinolol,3TBDMS,isomer #4 | CC(C)(C)N(CC(O)COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C | 3749.0 | Semi standard non polar | 33892256 | | Talinolol,3TBDMS,isomer #4 | CC(C)(C)N(CC(O)COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)[Si](C)(C)C(C)(C)C | 3340.4 | Standard non polar | 33892256 | | Talinolol,4TBDMS,isomer #1 | CC(C)(C)N(CC(COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3931.7 | Semi standard non polar | 33892256 | | Talinolol,4TBDMS,isomer #1 | CC(C)(C)N(CC(COC1=CC=C(N(C(=NC2CCCCC2)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3455.8 | Standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Talinolol GC-MS (Non-derivatized) - 70eV, Positive | splash10-05ai-8392000000-83257417c492bcc02837 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Talinolol GC-MS (2 TMS) - 70eV, Positive | splash10-0006-7113900000-a6077c88de0d3e3bdd61 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Talinolol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 10V, Positive-QTOF | splash10-03ds-7359000000-fa4e7f40cdd9d31c529d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 20V, Positive-QTOF | splash10-0012-9331000000-ff64a5bb6dd4e7c4e45f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 40V, Positive-QTOF | splash10-05g1-9100000000-4ff309b0d87ee718cd03 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 10V, Negative-QTOF | splash10-03ej-6395000000-c1e8876010d999b8c42a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 20V, Negative-QTOF | splash10-0532-8980000000-87c16685681ca293ab78 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 40V, Negative-QTOF | splash10-052b-9800000000-e511492383e670cf941f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 10V, Positive-QTOF | splash10-03di-0019000000-35ebc583929674e96e9c | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 20V, Positive-QTOF | splash10-0a4l-3097000000-56f249cfe9e89fe3f18a | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 40V, Positive-QTOF | splash10-0a59-9110000000-9d15e72acd624a5e2b67 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 10V, Negative-QTOF | splash10-03di-0019000000-e429dd470d6e20427360 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 20V, Negative-QTOF | splash10-03xs-5597000000-a8f8f30fdfdc6b6863bf | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Talinolol 40V, Negative-QTOF | splash10-000f-7920000000-4d5dac648968e2e95d96 | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|